SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016648
Filing Date
2023-05-12
Accepted
2023-05-12 16:18:25
Documents
56
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1113778
2 ex31-1.htm EX-31.1 14692
3 ex31-2.htm EX-31.2 14777
4 ex32-1.htm EX-32.1 6370
5 ex32-2.htm EX-32.2 6204
  Complete submission text file 0001493152-23-016648.txt   3955783

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rnxt-20230331.xsd EX-101.SCH 24997
7 XBRL CALCULATION FILE rnxt-20230331_cal.xml EX-101.CAL 33071
8 XBRL DEFINITION FILE rnxt-20230331_def.xml EX-101.DEF 103823
9 XBRL LABEL FILE rnxt-20230331_lab.xml EX-101.LAB 245814
10 XBRL PRESENTATION FILE rnxt-20230331_pre.xml EX-101.PRE 192049
50 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 394822
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

IRS No.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40738 | Film No.: 23916047
SIC: 2834 Pharmaceutical Preparations